Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2009 - 2026)

Idexx Laboratories has reported Non-Current Deferred Tax Liability for 18 years, with the latest figure at $52.6 million in Q2 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability rose 2420.98% year-over-year to $52.6 million in Q2 2026; TTM through Jun 2026 was $52.6 million, a 2420.98% increase from a year earlier, with the FY2025 full-year figure at $31.9 million, down 75.89% from the prior year.
• Non-Current Deferred Tax Liability was $52.6 million for Q2 2026 at Idexx Laboratories, up from $44.6 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $132.2 million in Q4 2024, with the low at $2.1 million in Q2 2025.
• Average Non-Current Deferred Tax Liability over 5 years is $31.3 million, with a median of $10.3 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Non-Current Deferred Tax Liability plunged 79.17% in 2025, then jumped 2420.98% in 2026.
• Over 5 years, Non-Current Deferred Tax Liability stood at $97.3 million in 2022, then climbed by 14.38% to $111.3 million in 2023, then gained by 18.73% to $132.2 million in 2024, then slumped by 75.89% to $31.9 million in 2025, then jumped by 65.19% to $52.6 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $52.6 million (Q2 2026), $44.6 million (Q1 2026), and $31.9 million (Q4 2025), per Business Quant data.